Abstract |
|
Authors | Marzia Del Re, Lucia Del Mastro |
Journal | Recenti progressi in medicina
(Recenti Prog Med)
Vol. 109
Issue 11
Pg. 531-539
(Nov 2018)
ISSN: 2038-1840 [Electronic] Italy |
Vernacular Title | Biosimilari in oncologia. SB3: dagli studi preclinici agli studi clinici. |
PMID | 30565572
(Publication Type: Comparative Study, Journal Article, Review)
|
Chemical References |
- Antineoplastic Agents, Immunological
- Biosimilar Pharmaceuticals
- ERBB2 protein, human
- Receptor, ErbB-2
- Trastuzumab
|
Topics |
- Antineoplastic Agents, Immunological
(administration & dosage, adverse effects)
- Biosimilar Pharmaceuticals
(administration & dosage, adverse effects)
- Breast Neoplasms
(drug therapy)
- Female
- Humans
- Neoadjuvant Therapy
(methods)
- Receptor, ErbB-2
(metabolism)
- Trastuzumab
(administration & dosage, adverse effects)
- Treatment Outcome
|